To find out more about the Clinical Drug Testing Biochip, enquire now.

Quicker and more targeted treatment enhances recovery rates and lowers mortality and morbidity.
Biochip simultaneously screens for multiple substances to rapidly direct clinicians to the next steps and efficiently progress an effective treatment plan.
The process requires minimal sample preparation, with results in less than 30 minutes. The Biochip is reliable for drug screening, as it provides semi-quantitative concentrations of substances and metabolites.
Covering a range of drug classes, including common, prescription, and synthetic drugs, Biochip delivers multi-analyte detection, while eliminating the constraints of batch testing.
The multiplex Clinical Drug Testing Biochip provides clinicians with a semi-quantitative comprehensive drug screen in patients for various medical reasons including but not limited to; those presenting acute overdose symptoms, screening for clinical trial eligibility and recurring prescription management. The preliminary test result can assist clinicians in identifying recent illicit drug use, as part of their clinical management workflow.
humidity_low Sample Type:
Urine, Blood & Oral Fluid
update Time to Result:
Under 30 Minutes

The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers.
Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.
With minimal sample preparation required, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.

The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.
The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.
No other components are required.